X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6803) 6803
Publication (1199) 1199
Book Review (51) 51
Book Chapter (40) 40
Conference Proceeding (11) 11
Dissertation (11) 11
Book / eBook (7) 7
Journal / eJournal (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3595) 3595
index medicus (3148) 3148
aspergillus fumigatus (2403) 2403
microbiology (2073) 2073
animals (1925) 1925
aspergillus-fumigatus (1873) 1873
male (1482) 1482
female (1379) 1379
infectious diseases (1145) 1145
fungi (1115) 1115
immunology (1108) 1108
mice (1099) 1099
aspergillus fumigatus - isolation & purification (1076) 1076
mycology (1020) 1020
aspergillosis - microbiology (954) 954
candida-albicans (922) 922
aspergillosis (879) 879
antifungal agents - pharmacology (877) 877
aspergillus fumigatus - drug effects (847) 847
adult (808) 808
invasive aspergillosis (794) 794
virulence (759) 759
aspergillus fumigatus - immunology (739) 739
middle aged (733) 733
antifungal agents - therapeutic use (727) 727
aspergillus fumigatus - genetics (722) 722
aspergillus (699) 699
infections (685) 685
aspergillosis - drug therapy (653) 653
pharmacology & pharmacy (587) 587
microbial sensitivity tests (558) 558
infection (548) 548
mycoses (547) 547
aspergillus fumigatus - pathogenicity (528) 528
analysis (505) 505
aspergillosis - diagnosis (490) 490
fungal proteins - genetics (486) 486
antifungal agents (480) 480
research article (480) 480
health aspects (452) 452
voriconazole (435) 435
diagnosis (434) 434
aged (433) 433
aspergillosis - immunology (422) 422
cryptococcus-neoformans (416) 416
biochemistry & molecular biology (413) 413
research (413) 413
aspergillus fumigatus - metabolism (411) 411
proteins (407) 407
amphotericin-b (402) 402
disease models, animal (402) 402
saccharomyces-cerevisiae (402) 402
pulmonary aspergillosis (377) 377
fungal proteins - metabolism (376) 376
in-vitro (376) 376
veterinary sciences (366) 366
fungal-infections (358) 358
aspergillus fumigatus - growth & development (357) 357
aspergillosis - pathology (321) 321
life sciences (321) 321
itraconazole (316) 316
fumigatus (315) 315
physiological aspects (308) 308
molecular sequence data (302) 302
article (300) 300
aspergillus fumigatus - physiology (299) 299
pathogens (296) 296
adolescent (291) 291
medicine (287) 287
mutation (286) 286
respiratory system (285) 285
identification (283) 283
epidemiology (281) 281
inflammation (280) 280
fungal infections (276) 276
lung - microbiology (274) 274
biology (271) 271
gene expression (269) 269
invasive pulmonary aspergillosis (269) 269
macrophages (265) 265
expression (261) 261
immunocompromised host (260) 260
cell biology (258) 258
skin and connective tissue diseases (258) 258
aspergillosis - complications (256) 256
mice, inbred balb c (251) 251
amphotericin b - therapeutic use (248) 248
child (247) 247
multidisciplinary sciences (246) 246
mycoses - microbiology (245) 245
biotechnology & applied microbiology (240) 240
medical microbiology (240) 240
resistance (239) 239
yeast (238) 238
cystic fibrosis (237) 237
drug resistance, fungal (237) 237
gene expression regulation, fungal (232) 232
dendritic cells (231) 231
conidia (230) 230
aspergillus fumigatus - enzymology (229) 229
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6499) 6499
French (99) 99
German (63) 63
Spanish (60) 60
Japanese (35) 35
Polish (19) 19
Turkish (14) 14
Italian (6) 6
Korean (6) 6
Portuguese (6) 6
Russian (6) 6
Chinese (5) 5
Dutch (4) 4
Czech (3) 3
Afrikaans (2) 2
Bulgarian (2) 2
Arabic (1) 1
Danish (1) 1
Finnish (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 11, pp. 1136 - 1149
Summary The emergence and spread of antimicrobial-resistant bacterial, viral, and fungal pathogens for which diminishing treatment options are available is of... 
Infectious Disease | INFECTIOUS DISEASES | INFLUENZA-A | ASPERGILLUS-FUMIGATUS | IN-VITRO | VIRUS-INFECTION | A DOUBLE-BLIND | OPEN-LABEL | CRITICALLY-ILL PATIENTS | T-CELLS | SYNDROME CORONAVIRUS | H1N1 VIRUS | Mycoses - epidemiology | Virus Diseases - epidemiology | Biological Therapy - methods | Biological Therapy - trends | Humans | Drug Resistance, Viral | Drug Resistance, Bacterial | Mycoses - microbiology | Virus Diseases - virology | Antifungal Agents - therapeutic use | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Virus Diseases - drug therapy | Respiratory Tract Infections - virology | Drug Resistance, Fungal | Bacterial Infections - microbiology | Drug Therapy - trends | Antifungal Agents - pharmacology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Drug Discovery - trends | Respiratory Tract Infections - drug therapy | Treatment Outcome | Drug Therapy - methods | Bacterial Infections - epidemiology | Mycoses - drug therapy | Anti-Bacterial Agents - pharmacology | Respiratory Tract Infections - epidemiology | Antiviral agents | Hospitals | Influenza | Mycoses | Development and progression | Bacteria | Cross infection | Nosocomial infections | Drug therapy | Cells | Drug resistance in microorganisms | Severe acute respiratory syndrome | Respiratory agents | Pandemics | Mortality | Respiratory diseases | Viral infections
Journal Article